Sanofi Consumer Healthcare India Limited announced the Appointment of Mr. Surendra Agarwal as Chief Financial Officer. With effect from 6th June 2024. Mr. Surendra K. Agarwal has With over 20 years' experience in Sanofi and an overall experience of 30 years in Finance, Surendra has discharged roles of increasing responsibilities in Accounting, Taxation, Finance Business Partner of Commercial and Industrial operations, Internal Control & Audit, Cost Audit, NPPA pricing compliance and Supply Chain.

In his most recent assignment, he was in-charge of the accounting function for India, Nepal, and Sri Lanka Operations. He handled additional roles of Vaccines Public Market sales, Real Estate Projects, Zeal Project support towards Shantha operations and merger of the Triple entities in India. In his current role, he is responsible for all finance aspects and obligations before the Board and Audit Committee, A2R activities and sign-off of accounts for both local and corporate financial statements.

As a member of the Management Committee and A2R Leadership Team, Surendra is responsible for quarterly and year end accounts reviews by statutory auditor, results approved by Audit Committee prior to publishing to the Indian stock exchanges, reviews of related party transactions & Budgets of the listed entity approval from Audit Committee, interface and linkage between business performance and Independent Board members on financial matters, reviewing the disclosure obligations under the Listing Obligations and Disclosure Requirements (LODR) in consultation with Company Secretary, close interactions with Head of Finance Performance, Supply Chain & Customer service and with Commercial Operations leaders and ongoing interactions with GBS Stream (A2R, S2V, CI2C, Tax and PSS) in order to have best in class delivery and strategic alignment. He joined Sanofi as Head of Finance Operations (HFO), Consumer Healthcare Business. Surendra is a Cost & Management Accountant (CMA) from ICMAI and master's in finance from University of Kolkata.